Nabumetone Tablet
Product Images NDC 68788-7597

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 68788-7597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nabumentone Tablets 750mg (Container3)

Nabumentone Tablets 750mg (Container3)
This is a label description of a generic medicine equivalent to Relafen, called Nabumetone Tablets 750mg. It includes information such as the manufacturer, package size, expiration date, and NDC code.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This is a chart showing the plasma concentrations of Nabumetone Active Metabolite (BMNA) at steady state after once-daily dosing of Nabumetone 1000 mg and 2000 mg in a group of 31 and 12 individuals respectively. The chart displays plasma concentrations over time in hours, with different dosing regimens shown in different colors.*
FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.